Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013 (2013), Article ID 281291, 8 pages
http://dx.doi.org/10.1155/2013/281291
Research Article

Effect of Androgen Blockade on HER-2 and Matrix Metalloproteinase-2 Expression on Bone Marrow Micrometastasis and Stromal Cells in Men with Prostate Cancer

1Hospital de Carabineros of Chile, Simón Bolívar 2200 Ñuñoa, 7770199 Santiago, Chile
2Circulating Tumor Cell Unit, Faculty of Medicine, University Mayor, Renato Sánchez 4369, Las Condes, 27550224 Santiago, Chile
3Institute of Bio-Oncology, Avenida Salvador 95, Oficina 513, Providencia, 7500710 Santiago, Chile
4Universidad Diego Portales, Manuel Rodriguez Sur 415, 8370179 Santiago, Chile
5Foundation of Arturo López Pérez, Rancagua 878, Providencia, 7500921 Santiago, Chile

Received 31 January 2013; Accepted 4 April 2013

Academic Editors: R. Amato and S. Srinivas

Copyright © 2013 N. P. Murray et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Huggins, “Effect of orquidectomy and irradiation on cancer of the prostate,” Annals of Surgery, vol. 115, pp. 1192–1200, 1942. View at Google Scholar
  2. L. A. Klein, “Prostatic carcinoma,” The New England Journal of Medicine, vol. 300, pp. 26–33, 1996. View at Google Scholar
  3. A. Yagoda and D. Petrylak, “Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer,” Cancer, vol. 71, no. 3, pp. 1098–1109, 1993. View at Google Scholar · View at Scopus
  4. J. D. Debes and D. J. Tindall, “Mechanisms of androgen-refractory prostate cancer,” The New England Journal of Medicine, vol. 351, no. 15, pp. 1488–1490, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Signoretti, R. Montironi, J. Manola et al., “Her-2-neu expression and progression toward androgen independence in human prostate cancer,” Journal of the National Cancer Institute, vol. 92, no. 23, pp. 1918–1925, 2000. View at Google Scholar · View at Scopus
  6. I. Osman, H. I. Scher, M. Drobnjak et al., “HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer,” Clinical Cancer Research, vol. 7, no. 9, pp. 2643–2647, 2001. View at Google Scholar · View at Scopus
  7. N. Craft, Y. Shostak, M. Carey, and C. L. Sawyers, “A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase,” Nature Medicine, vol. 5, no. 3, pp. 280–285, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. N. P. Murray, L. V. Badinez, R. R. Dueñas, N. Orellana, and P. Tapia, “Positive HER-2 protein expression in circulating prostate cells and micro-metastasis, resistant to androgen blockage but not diethylstilbestrol,” Indian Journal of Urology, vol. 27, no. 2, pp. 200–207, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Y. Jang, Y. K. Jeon, and C. W. Kim, “Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells,” BMC Cancer, vol. 10, article 391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Trudel, Y. Fradet, F. Meyer, F. Harel, and B. Têtu, “Significance of MMP-2 expression in prostate cancer: an Immunohistochemical Study,” Cancer Research, vol. 63, no. 23, pp. 8511–8515, 2003. View at Google Scholar · View at Scopus
  11. D. Trudel, Y. Fradet, F. Meyer, F. Harel, and B. Têtu, “Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry,” Human Pathology, vol. 39, no. 5, pp. 731–739, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. W. D. Zhong, Z. D. Han, H. C. He et al., “CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer,” Oncology, vol. 75, no. 3-4, pp. 230–236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Stearns and M. E. Steams, “Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression,” Oncology Research, vol. 8, no. 2, pp. 69–75, 1996. View at Google Scholar · View at Scopus
  14. L. J. ) Xiao, P. Lin, F. Lin, W. Qin, H. F. Zou, L. Guo et al., “ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion,” International Journal of Oncology, vol. 40, pp. 1714–1724, 2012. View at Google Scholar
  15. L. E. Littlepage, M. D. Sternlicht, N. Rougier et al., “Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression,” Cancer Research, vol. 70, no. 6, pp. 2224–2234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Borgen, B. Naume, J. M. Nesland et al., “Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells: the European ISHAGE working group for Standardization of Tumor Cell Detection,” Cytotherapy, vol. 1, no. 5, pp. 377–388, 1999. View at Google Scholar · View at Scopus
  17. I. J. Fidler, “The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisted,” Nature Reviews Cancer, vol. 3, pp. 453–458, 2003. View at Google Scholar
  18. K. Pantel, T. Enzmann, J. Kollermann, J. Caprano, G. Reithmuller, and M. W. Kollerman, “Immunocytochemical monitoring of micrometastatic disease reduction of prostate 11. cancer cells in bone marrow by androgen deprivation,” International Journal of Cancer, vol. 71, pp. 521–525, 1997. View at Google Scholar
  19. J. Köllermann, S. Weikert, M. Schostak et al., “Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment,” Journal of Clinical Oncology, vol. 26, no. 30, pp. 4928–4933, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Minner, B. Jessen, L. Stiedenroth et al., “Low level Her2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer,” Clinical Cancer Research, vol. 16, no. 5, pp. 1553–1560, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Shi, S. J. Chatterjee, F. H. Brands et al., “Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations,” BJU International, vol. 97, no. 1, pp. 170–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. D'Antonio, C. Ma, F. A. Monzon, and B. R. Pflug, “Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence,” Prostate, vol. 68, no. 7, pp. 698–714, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Wen, M. C. T. Hu, K. Makino et al., “HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway,” Cancer Research, vol. 60, no. 24, pp. 6841–6845, 2000. View at Google Scholar · View at Scopus
  24. S. Yeh, H. K. Lin, H. Y. Kang, T. H. Thin, M. F. Lin, and C. Chang, “From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 10, pp. 5458–5463, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Guyader, J. Ceraline, E. Gravier, A. Morin, S. Michel, E. Erdmann et al., “Risk of hormoneescape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors,” Plos ONE, vol. 7, no. 8, 2012. View at Google Scholar
  26. X. Liao, J. B. Thrasher, J. Pelling, J. Holzbeierlein, Q. X. A. Sang, and B. Li, “Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer,” Endocrinology, vol. 144, no. 5, pp. 1656–1663, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. W. Bao, H. J. Fu, L. T. Jia et al., “HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion,” Archives of Biochemistry and Biophysics, vol. 499, no. 1-2, pp. 49–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Ke, H. Lin, Z. Fan et al., “MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2,” International Journal of Cancer, vol. 119, no. 1, pp. 8–16, 2006. View at Publisher · View at Google Scholar · View at Scopus